American International Group’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-7,161
| Closed | -$132 | – | 3189 |
|
|
2020
Q4 | $132 | Sell |
7,161
-207
| -3% | -$3.77K | ﹤0.01% | 2511 |
|
|
2020
Q3 | $135K | Sell |
7,368
-167
| -2% | -$2.81K | ﹤0.01% | 2363 |
|
|
2020
Q2 | $113K | Buy |
7,535
+372
| +5% | +$5.31K | ﹤0.01% | 2463 |
|
|
2020
Q1 | $113K | Sell |
7,163
-414
| -5% | -$6.69K | ﹤0.01% | 2239 |
|
|
2019
Q4 | $123K | Sell |
7,577
-63
| -0.8% | -$1.05K | ﹤0.01% | 2503 |
|
|
2019
Q3 | $114K | Sell |
7,640
-54
| -0.7% | -$728 | ﹤0.01% | 2528 |
|
|
2019
Q2 | $127K | Buy |
7,694
+294
| +4% | +$4.8K | ﹤0.01% | 2528 |
|
|
2019
Q1 | $128K | Sell |
7,400
-239
| -3% | -$4.34K | ﹤0.01% | 2478 |
|
|
2018
Q4 | $135K | Sell |
7,639
-58
| -0.8% | -$985 | ﹤0.01% | 2427 |
|
|
2018
Q3 | $140K | Buy |
7,697
+138
| +2% | +$2.83K | ﹤0.01% | 2647 |
|
|
2018
Q2 | $148K | Buy |
+7,559
| New | +$142K | ﹤0.01% | 2550 |
|
|
2017
Q2 | – | Sell |
-7,487
| Closed | -$88K | – | 3149 |
|
|
2017
Q1 | $88K | Buy |
7,487
+496
| +7% | +$6.02K | ﹤0.01% | 2657 |
|
|
2016
Q4 | $92K | Sell |
6,991
-19
| -0.3% | -$254 | ﹤0.01% | 2652 |
|
|
2016
Q3 | $102K | Buy |
7,010
+10
| +0.1% | +$142 | ﹤0.01% | 2588 |
|
|
2016
Q2 | $83.9K | Buy |
7,000
+1,238
| +21% | +$19.9K | ﹤0.01% | 2734 |
|
|
2016
Q1 | $107K | Hold |
5,762
| – | – | ﹤0.01% | 3378 |
|
|
2015
Q4 | $124K | Sell |
5,762
-10
| -0.2% | -$211 | ﹤0.01% | 3313 |
|
|
2015
Q3 | $98K | Buy |
5,772
+6
| +0.1% | +$149 | ﹤0.01% | 3502 |
|
|
2015
Q2 | $216K | Buy |
+5,766
| New | +$186K | ﹤0.01% | 2942 |
|
American International Group's CBMG Position: Q1 2021 in Review
American International Group sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 7,161 shares — an estimated $132 sold.
American International Group first reported a position in CBMG in Q2 2015 and held it in 19 quarters. The position peaked at $216K in Q2 2015. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.
- American International Group reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
- American International Group sold 7,161 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $132.
- American International Group first reported a position in Cellular Biomedicine Group, Inc. in Q2 2015 and held it in 19 quarters.
- American International Group's Cellular Biomedicine Group, Inc. position peaked at $216K in Q2 2015.
- 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.
Based on American International Group's 13F filing for Q1 2021, filed 7 May 2021.